MedPath

COmparing the use of Midline Catheters versus Peripherally Inserted Central CAtheters for patients requiring peripherally Compatible Therapies: A randomised controlled trial (the COMPACT Trial)

Not Applicable
Completed
Conditions
Catheter failure prior to completion of therapy
Public Health - Health service research
Infection - Other infectious diseases
Registration Number
ACTRN12620000112965
Lead Sponsor
Griffith University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
25
Inclusion Criteria

• Informed consent to participate
• The treating team have referred the patient to receive a PICC with peripherally-compatible intravenous therapy
• Patient expected to receive IV therapy for up to or equal to 29 days
• The treating team has approved the use of either a MC or PICC.

Exclusion Criteria

• Non-English speakers without interpreter
• Patient receiving end-of-life care
• Patient with a history of venous thromboembolism or renal disease
• Cognitive barrier to consent (without a SDM)
• Previous enrolment in this study
• Patient receiving chemotherapy treatment
• Patient lives outside Metro North Hospital and Health Service.
• History of intravenous drug use in the last one year

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath